RMD — RESMED INC

—
NYSE · Health Care · Health Care Equipment & Supplies · CIK 943819 ·
Last close
$237.85
Market Cap
$33.46B
52W High
$274.65
52W Low
$179.26
ADV30
1,346,900
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 1,414,814,000 870,567,000 452,984,000 418,413,000 8,211,811,000 1,010,742,000 2,264,121,000
Jun 2026 1,463,647,000 861,219,000 448,712,000 383,432,000 8,965,950,000 1,469,234,000 2,380,557,000
Mar 2026 1,431,406,000 890,979,000 499,810,000 398,732,000 8,784,285,000 1,660,513,000 2,292,374,000
Dec 2025 1,422,808,000 878,724,000 497,595,000 392,593,000 8,503,370,000 1,417,069,000 2,182,491,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$1,805,829,000
Investing CF
$-545,199,000
Financing CF
$-1,007,029,000
CapEx
$-177,173,000
Dividends Paid
$-349,662,000
Buybacks
$-700,037,000
EPS Diluted TTM
$10.43
As of
2026-11-01

Balance + Analyst (yfinance extras)

Retained Earnings
$7,255,121,000
Inventory
$945,805,000
Receivables
$1,084,953,000
ST Investments
—
EBIT TTM
$1,908,464,000
Pretax Income TTM
$1,919,417,000
Interest Exp TTM
—
Analysts
17

Yahoo Snapshot (yfinance, live)

Total Revenue
$5,732,675,072
EBITDA
$2,096,264,960
Free Cash Flow
$1,274,890,624
Enterprise Value
$32,478,726,144
Total Cash
$1,010,742,016
Total Debt
$610,577,984
Shares Out
140,657,071
Trailing EPS
$10.98
Book Value
$41.59
ROE
26.4%
ROA
14.6%
Div Yield
1.15%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Jun 2026 5,653,443,000 1,908,460,000 1,523,293,000 8,965,950,000 2,380,557,000 6,585,393,000 1,805,829,000
Jun 2025 5,146,327,000 1,685,363,000 1,400,723,000 8,174,391,000 2,206,532,000 5,967,859,000 1,751,588,000
Jun 2024 4,685,297,000 1,384,121,000 1,020,951,000 6,872,394,000 2,008,351,000 4,864,043,000 1,401,260,000
Jun 2023 4,222,993,000 1,151,997,000 897,556,000 6,751,708,000 2,621,805,000 4,129,903,000 693,299,000
Jun 2022 — — — — — — —

TTM Snapshot

Revenues TTM
$5,653,443,000
NetIncome TTM
$1,523,293,000
OpCashFlow TTM
—
Assets (Latest)
$8,784,285,000
Forward EPS
$13.23

Max Pain — expiry 2027-01-15

max pain strike: $250.00 · spot: $242.61 · call oi: 2,631 · put oi: 13,260
Expected Move to 2027-01-15: ±$23.92 (9.86%) — implied range $218.69 – $266.53 · ATM straddle on $240.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
FSNUY Fresenius SE & Co. KGaA $33.30B $14.78 —
MDLN Medline Inc. $33.11B $37.68 —
DXCM DEXCOM INC $30.60B $82.04 —
GEHC GE HealthCare Technologies Inc. $37.00B $81.84 —
PHG KONINKLIJKE PHILIPS NV $29.22B $29.89 —

News headlines (Yahoo Finance, 1h cache)

Global Virtual Sleep Clinics Market Report 2026: Forecast to 2030 | Capitalize on AI Diagnostics and Home Testing: ResMed, Philips, Teladoc, and Oura Drive Market to $3.46 Billion
2026-11-18 14:34 · Yahoo
Don’t Lose Sleep Over GLP-1s: Why ResMed Stock Is a Bargain
2026-11-07 03:04 · Yahoo
ResMed: 3 Key Takeaways for Long-Term Investors
2026-11-02 09:33 · Yahoo
What Sent ResMed Stock Lower?
2026-11-02 01:23 · Yahoo
RMD Q3 deep dive: product innovation and supply chain execution drive results amid evolving landscape
2026-10-31 23:07 · Yahoo
ResMed (RMD) Looks Fully Valued After Another Earnings Beat
2026-10-30 19:16 · Yahoo
ResMed (RMD) Q1 2027 Earnings Call Transcript
2026-10-30 15:00 · Yahoo
ResMed (RMD) Reports Q1 Earnings: What Key Metrics Have to Say
2026-10-30 12:30 · Yahoo
ResMed Inc. Q1 2027 Earnings Call Summary
2026-10-30 12:30 · Yahoo
What ResMed (RMD) Said on Its Q1 Earnings Call
2026-10-30 11:14 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.